Skyscape Web Viewer : EBMG: Oncology : Evidence summaries

View All
Cyclosporin A for Primary Biliary Cirrhosis
Cyclosporine A in Severe Ulcerative Colitis
Cyclosporine for Induction of Remission in Crohn's Disease
Cyclosporin for Psoriasis
Cyproterone Acetate for Hirsutism
Cytisine for Smoking Cessation
Cytomegalovirus Prophylaxis with Antiviral Agents for Solid Organ Transplantation
Cytotoxic and Hormonal Treatment for Metastatic Breast Cancer
Cabergoline for Levodopa-Induced Complications in Parkinson's Disease
Cabergoline Versus Bromocriptine for Levodopa-Induced Complications in Parkinson's Disease
Cabg Versus Ptca in Multi-Vessel Coronary Disease
Caffeine for Asthma
Calcimimetics for Secondary Hyperparathyroidism in Chronic Kidney Disease Patients
Calcineurin Inhibitor Withdrawal or Tapering for Kidney Transplant Recipients
Calcitonin for Corticosteroid-Induced Osteoporosis
Calcitonin for Metastatic Bone Pain
Calcium and Vitamin D for Corticosteroid-Induced Osteoporosis
Calcium Antagonists as an Add-on Therapy for Drug-Resistant Epilepsy
Calcium Antagonists for Aneurysmal Subarachnoid Haemorrhage
Calcium Antagonists for Stroke
Calcium Channel Blockers for Inhibiting Preterm Labour
Calcium Channel Blockers for Raynaud's Phenomenon
Calcium-Channel Blockers for Raynaud's Phenomenon in Systemic Sclerosis
Calcium Channel Blockers Versus other Classes of Drugs for Hypertension
Calcium Intake and Bone Loss
Calcium Supplementation (other Than for Preventing or Treating Hypertension) for Improving Pregnancy and Infant Outcomes
Calcium Supplementation during Pregnancy for Preventing Hypertensive Disorders
Calcium Supplementation for Improving Bone Mineral Density in Children
Cancer Genetic Risk Assessment for Individuals at Risk of Familial Breast Cancer
Cancer Incidence in Children Born after Assisted Reproductive Technologies